Verified Nov 2026
Other
·

Graefelfing, Bavaria
·
Since 2008
Futrue GmbH is a privately held healthcare group founded in 2008 and headquartered in Graefelfing, Bavaria, with 1,000–5,000 employees. The company operates as an incubator and holding company managing over 20 subsidiaries globally, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. It develops therapeutics in e-health, microbiome therapy, and pain management, with a portfolio exceeding 90 drug approvals including the Kijimea® brand for gastrointestinal and allergy disorders.
Futrue GmbH at a glance
Employees
1,000-5,000
Founded
2008
Headquarters
Graefelfing, Bavaria
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Futrue GmbH is a privately held healthcare group founded in 2008 and headquartered in Graefelfing, Bavaria, with 1,000–5,000 employees. The company operates as an incubator and holding company managing over 20 subsidiaries globally, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. It develops therapeutics in e-health, microbiome therapy, and pain management, with a portfolio exceeding 90 drug approvals including the Kijimea® brand for gastrointestinal and allergy disorders.
At a glance
Attribute | Detail |
|---|---|
Founded | 2008 |
Headquarters | Graefelfing, Bavaria |
Employees | 1,000-5,000 |
What Futrue GmbH makes
The company's capabilities span drug development, clinical research, regulatory affairs, and digital health solutions across therapeutic areas including neuromodulation and cost-effective clinical trials.
Latest developments
2026-11-08 — FUTRUE investiert über 100 Millionen Euro in den Aufbau des modernsten BCI-Entwicklungs- und Produktionszentrums Europas | Dr. Clemens Fischer (linkedin.com)
2026-11-06 — 100 Millionen für Hirnchips: Futrue fordert Neuralink (ms-aktuell.de)
2026-03-31 — FUTRUE Neurosciences gelingt wichtiger Meilenstein | Presseportal (presseportal.de)
2025-12-17 — Bayerns Ministerpräsident Dr. Markus Söder besucht FUTRUE, eines der am schnellsten ... | Presseportal (presseportal.de)
2025-07-24 — FUTRUE GmbH submits request to implement squeeze-out of minority shareholders of PharmaSGP Holding SE | MarketScreener (marketscreener.com)
Company details
Futrue operates as a privately held group with a majority stake in PharmaSGP Holding SE and manages a diversified portfolio of pharmaceutical and functional food products distributed internationally. Futrue GmbH was founded in 2008, has an estimated 1,000-5,000 employees, and is headquartered in Graefelfing, Bavaria.
Frequently asked questions
What does Futrue GmbH do?
Futrue GmbH is a privately held healthcare group founded in 2008 and headquartered in Graefelfing, Bavaria, with 1,000–5,000 employees. The company operates as an incubator and holding company managing over 20 subsidiaries globally, serving automotive, electric-vehicle, medical, and industrial-equipment sectors. It develops therapeutics in e-health, microbiome therapy, and pain management, with a portfolio exceeding 90 drug approvals including the Kijimea® brand for gastrointestinal and allergy disorders.
Where is Futrue GmbH headquartered?
Futrue GmbH is headquartered in Graefelfing, Bavaria.
When was Futrue GmbH founded?
Futrue GmbH was founded in 2008.
How big is Futrue GmbH?
Futrue GmbH has an estimated 1,000-5,000 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
